复星医药(02196)今日盘中大幅上涨5.21%，引起了市场的广泛关注。
消息面上，公司于前一日晚间及今日早间陆续发布了2025年年度报告。报告显示，2025年公司实现归属于上市公司股东的净利润33.71亿元人民币，同比增长21.69%；基本每股收益1.27元，同比增长22.12%。同时，公司公布了利润分配预案，拟向全体股东每10股派发现金红利3.9元（含税）。这份亮眼的业绩报告和分红计划显著增强了投资者信心。
此外，根据年报披露，公司创新药品收入在2025年达到98.93亿元，同比增长29.59%，成为业绩增长的重要引擎。全年研发总投入59.13亿元，其中创新药相关研发投入持续增长。这些积极的基本面因素共同推动了股价在今日盘中的强势表现。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.